Comparison of Quantitation of Cytomegalovirus DNA by Real-Time PCR in Whole Blood with the Cytomegalovirus Antigenemia Assay

논문상세정보
' Comparison of Quantitation of Cytomegalovirus DNA by Real-Time PCR in Whole Blood with the Cytomegalovirus Antigenemia Assay' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,576 0

0.0%

' Comparison of Quantitation of Cytomegalovirus DNA by Real-Time PCR in Whole Blood with the Cytomegalovirus Antigenemia Assay' 의 참고문헌

  • 거대세포바이러스 정량 검출을 위한 BiosewoomTM Real-Q CytomegalovirusQuantification kit 평가
    허운보 Annals of Laboratory Medicine 27 (4) : 298 ~ 304 [2007]
  • 거대세포바이러스 정량 검출을 위한 BiosewoomTM Real-Q CytomegalovirusQuantification kit 평가
    허운보 Annals of Laboratory Medicine 27 4 298-304 [2007]
  • Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection
    Kalpoe JS J Clin Microbiol 42 : 1498 ~ 1504 [2004]
  • Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection
    Kalpoe JS J Clin Microbiol 42 1498-1504 [2004]
  • Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
    Kotton CN Transplantation 96 : 333 ~ 360 [2013]
  • Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
    Kotton CN Transplantation 96 333-360 [2013]
  • The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease
    Razonable RR Transplantation 73 : 968 ~ 973 [2002]
  • The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease
    Razonable RR Transplantation 73 968-973 [2002]
  • The challenge of CMV infection and disease in transplantation
    Griffiths PD - [2000]
  • Recommendations from the International Herpes Management Forum (IHMF) Managements Strategies Workshop and 8th Annual Meeting of the IHMF. The challenge of CMV infection and disease in transplantation
    Griffiths PD Cambridge Medical Publications [2000]
  • Realtime quantitative PCR
    Heid CA Genome Res 6 : 986 ~ 994 [1996]
  • Realtime quantitative PCR
    Heid CA Genome Res 6 986-994 [1996]
  • Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients
    Kim DJ Transplant Proc 39 : 1458 ~ 1460 [2007]
  • Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients
    Kim DJ Transplant Proc 39 1458-1460 [2007]
  • Quantitation of cytomegalovirus: methodologic aspects and clinical applications
    Boeckh M Clin Microbiol Rev 11 : 533 ~ 554 [1998]
  • Quantitation of cytomegalovirus: methodologic aspects and clinical applications
    Boeckh M Clin Microbiol Rev 11 533-554 [1998]
  • Quantification of cytomegalovirus viral load
    Pillet S Expert Rev Anti Infect Ther 12 : 193 ~ 210 [2014]
  • Quantification of cytomegalovirus viral load
    Pillet S Expert Rev Anti Infect Ther 12 193-210 [2014]
  • Prevention of cytomegalovirus disease in recipients of solid-organ transplants
    Paya CV Clin Infect Dis 32 : 596 ~ 603 [2001]
  • Prevention of cytomegalovirus disease in recipients of solid-organ transplants
    Paya CV Clin Infect Dis 32 596-603 [2001]
  • Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial
    Paya CV J Infect Dis 185 : 854 ~ 860 [2002]
  • Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial
    Paya CV J Infect Dis 185 854-860 [2002]
  • Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR
    Ghaffari SH Pathol Oncol Res 14 : 399 ~ 409 [2008]
  • Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR
    Ghaffari SH Pathol Oncol Res 14 399-409 [2008]
  • Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients
    Li H J Clin Microbiol 41 : 187 ~ 191 [2003]
  • Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients
    Li H J Clin Microbiol 41 187-191 [2003]
  • High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay
    Von Müller L J Clin Microbiol 40 : 2285 ~ 2287 [2002]
  • High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay
    Von Müller L J Clin Microbiol 40 2285-2287 [2002]
  • Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment
    Allice T J Virol Methods 148 : 9 ~ 16 [2008]
  • Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment
    Allice T J Virol Methods 148 9-16 [2008]
  • Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients
    Guiver M Transplantation 71 : 1609 ~ 1615 [2001]
  • Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients
    Guiver M Transplantation 71 1609-1615 [2001]
  • Definitions of cytomegalovirus infection and disease in transplant recipients
    Ljungman P Clin Infect Dis 34 : 1094 ~ 1097 [2002]
  • Definitions of cytomegalovirus infection and disease in transplant recipients
    Ljungman P Clin Infect Dis 34 1094-1097 [2002]
  • Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants
    Marchetti S New Microbiol 34 : 157 ~ 164 [2011]
  • Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants
    Marchetti S New Microbiol 34 157-164 [2011]
  • Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients
    Mhiri L J Virol Methods 143 : 23 ~ 28 [2007]
  • Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients
    Mhiri L J Virol Methods 143 23-28 [2007]
  • Comparison of Quantitative Cytomegalovirus Real-time PCR in Whole Blood and pp65 Antigenemia Assay: Clinical Utility of CMV Real-time PCR in Hematopoietic Stem Cell Transplant Recipients
    최수미 Journal of Korean Medical Science 24 (4) : 571 ~ 578 [2009]
  • Comparison of Quantitative Cytomegalovirus Real-time PCR in Whole Blood and pp65 Antigenemia Assay: Clinical Utility of CMV Real-time PCR in Hematopoietic Stem Cell Transplant Recipients
    최수미 Journal of Korean Medical Science 24 4 571-578 [2009]
  • Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation
    Camargo LF Transplantation 71 : 412 ~ 417 [2001]
  • Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation
    Camargo LF Transplantation 71 412-417 [2001]
  • Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients
    Lilleri D J Med Virol 73 : 412 ~ 418 [2004]
  • Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients
    Lilleri D J Med Virol 73 412-418 [2004]
  • Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalovirus infection in kidney transplant recipients
    Rhee JY Transplant Proc 43 : 2624 ~ 2629 [2011]
  • Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalovirus infection in kidney transplant recipients
    Rhee JY Transplant Proc 43 2624-2629 [2011]